Delhi Pharmaceutical Sciences And Research University
- Overall Grade: not available yet
- State Public University
- Location: South, Delhi
- No reviews yetWrite a review
Updated
Delhi Pharmaceutical Sciences And Research University Admissions & Acceptance
Admissions
Nothing you sit decides an undergraduate seat. Admission to the diploma and undergraduate programmes is on the merit of the qualifying examination, and it is the postgraduate side that runs on entrance scores, as the 2026-27 notification puts it in a single line. That line contradicts most of what circulates about this university, where third-party pages routinely file the B.Pharm under CUET-UG.
The arithmetic behind the undergraduate merit list is spelled out and narrow. Only three Class 12 subjects count, physics, chemistry and biology or mathematics, theory and practical taken together, and a candidate who offered both biology and mathematics has the better of the two counted as the third subject. The floor is 55% in that aggregate and in each of the three subjects, relaxed by 5% for Scheduled Caste, Scheduled Tribe, Other Backward Class and disabled candidates, and a compartment or supplementary in the qualifying examination disqualifies outright, in the eligibility pages of the prospectus. Nothing else in a school record moves the position.
At postgraduate level an entrance score comes first and academic marks come second, in a two-stage sequence that is often misread as a single rule.
| Programme group | What decides the merit list |
|---|---|
| D.Pharm, B.Pharm, B.Pharm (Ayurveda) and the other undergraduate courses | Marks in the qualifying examination |
| M.Pharm | GPAT rank or score, with a separate non-GPAT list drawn on B.Pharm marks |
| MBA | CUET |
| The remaining postgraduate courses | CUET or GPAT and merit of academic score, as the course requires |
Sources: DPSRU's 2026-27 and 2024-25 admissions notifications.
The non-GPAT route is real, and it is not a side entrance. Where seats remain vacant after the first round of counselling, the second round admits non-GPAT and non-CUET candidates on the merit of their academic score, as the notification sets out. GPAT-qualified candidates are simply considered first. A strong B.Pharm aggregate with no GPAT attempt still has a path into the master's, and that path opens later in the calendar than most applicants expect.
Where the M.Pharm becomes genuinely unusual is the way its seats are cut before merit is even applied. 15% of the seats in every M.Pharm course go to non-Delhi candidates, a group that expressly includes the NCR towns. The remaining 85% go to graduates of Delhi colleges and universities, and inside that block 70% is set aside for DIPSAR and DPSRU's own graduates with 15% left for Delhi graduates from anywhere else, in the basis of selection for M.Pharm. Only if that 70% share goes unfilled are the other Delhi candidates considered against it. Three separate contests, not one.
That is why DPSRU's published merit lists come in sets rather than pairs: one for Delhi undergraduate applicants, one for everyone else, and at M.Pharm a list confined to the university's own B.Pharm graduates. Where you sat your board exam and where you took your bachelor's both change which queue you join, and neither can be fixed at application time.
One postgraduate condition sits outside the merit list altogether and catches people after they have paid. Every student admitted to a postgraduate pharmacy programme must already hold registration with a State Pharmacy Council or apply for it within one month of admission, and the admission is cancelled if they do not, under the Pharmacy Council notification the prospectus reproduces.
Two procedural rules govern the rest of it. Applications are filled and submitted online while counselling is held in person, and the 2026-27 cycle was advertised to commence from 22 May 2026, in the same notification. Candidates are then called one at a time in merit order, with the older candidate preferred where marks are identical, per the admission procedure in the prospectus. A seat becomes yours only when the fee is paid at the counselling table, so arrange the money before you travel to Pushp Vihar.
Admissions Statistics
Delhi category
Highest aggregate on the list · 2025-26 merit list, diploma and undergraduate courses
Seats
2023-24 · Undergraduate sanctioned intake · Academic year
Sanctioned (approved) intake
| Academic year | UG [4 Years Program(s)] | PG [2 Year Program(s)] |
|---|---|---|
| 2023-24 | 160 | 115 |
| 2022-23 | 160 | 140 |
| 2021-22 | 160 | Not published |
| 2020-21 | 120 | Not published |
| 2019-20 | Not published | Not published |
| 2018-19 | Not published | Not published |
First-year admissions
| Programme | Academic year | First-year intake | Admitted |
|---|---|---|---|
| UG [4 Years Program(s)] | 2020-21 | 120 | 132 |
| UG [4 Years Program(s)] | 2019-20 | 120 | 132 |
| UG [4 Years Program(s)] | 2018-19 | 120 | 116 |
| UG [4 Years Program(s)] | 2017-18 NIRF data 2024 | 120 | 105 |
| UG [4 Years Program(s)] | 2016-17 NIRF data 2023 | 120 | 95 |
| PG [2 Years Program(s)] | 2022-23 | 140 | 124 |
| PG [2 Years Program(s)] | 2021-22 | 155 | 125 |
| PG [2 Years Program(s)] | 2020-21 | 125 | 129 |
| PG [2 Years Program(s)] | 2019-20 NIRF data 2024 | 125 | 107 |
| PG [2 Years Program(s)] | 2018-19 NIRF data 2023 | 98 | 90 |
Admitted through lateral entry
| Programme | Academic year | Lateral entry |
|---|---|---|
| UG [4 Years Program(s)] | 2021-22 | 20 |
| UG [4 Years Program(s)] | 2020-21 | 22 |
| UG [4 Years Program(s)] | 2019-20 | 21 |
| UG [4 Years Program(s)] | 2018-19 NIRF data 2024 | 22 |
| UG [4 Years Program(s)] | 2017-18 NIRF data 2023 | 30 |
Data source: NIRF data for Pharmacy only – data submitted for India Rankings 2025, 2024 and 2023
Cutoff
DPSRU publishes no closing rank and no closing percentage. What it publishes instead, cycle after cycle, is the entire merit list with every applicant's aggregate printed beside their name, and that document describes the real threshold better than a cutoff table would.
| 2025-26 merit list, diploma and undergraduate courses | Candidates listed | Highest aggregate on the list |
|---|---|---|
| Delhi category | 2,824 | 97 |
| Outside Delhi | 2,229 | 100 |
Sources: DPSRU's merit lists for Delhi and outside Delhi candidates.
Both lists cover every diploma and undergraduate course together rather than B.Pharm alone, so they measure appetite for the campus rather than for one degree. The eligibility floor is printed at the foot of each list: candidates scoring below 55% are generally not eligible, with a relaxation of 5% for Scheduled Caste, Scheduled Tribe, Other Backward Class and disabled candidates, on the Delhi list. That bar, and not a competitive cutoff, is the only number the university commits to in advance.
Read those two counts against the seat split and the outside-Delhi position is harder than the table suggests. Almost as many outside-Delhi candidates queued as Delhi ones, yet only 15% of the places in each course are open to them, under the outside-Delhi rule in the prospectus. The same Class 12 aggregate buys a very different outcome depending on which of the two lists it lands on.
The master's picture is smaller and much sharper. The outside-Delhi GPAT list for 2025-26 ran to 253 candidates and was topped by a GPAT score of 329, as published. The non-GPAT list restricted to DPSRU's own graduates carried 41 names and opened at an aggregate of 82.55, on its own list. Those two documents describe entirely different contests for seats in the same classrooms, which is the strongest argument for taking GPAT seriously if you studied your bachelor's anywhere else.
Seats do not all go in the first round, and that is the practical opening for a late applicant. The university issued vacant-seat statements after the first round of counselling for the M.Pharm programmes at both DIPSAR and the School of Pharmaceutical Sciences and ran further rounds against them. Anyone who misses the first list should be watching those vacancy notices rather than waiting for the next admission year.
Seat Matrix
The undergraduate sanction stepped up once and has not moved since; the postgraduate one has travelled the other way.
| Academic year | Undergraduate sanctioned intake | Postgraduate sanctioned intake |
|---|---|---|
| 2023-24 | 160 | 115 |
| 2022-23 | 160 | 140 |
| 2021-22 | 160 | not reported |
| 2020-21 | 120 | not reported |
Those undergraduate totals are the two ordinary B.Pharm streams added together, 100 at DIPSAR and 60 at the School of Pharmaceutical Sciences, as the prospectus seat matrix sets them out. The number admitted has run ahead of the number sanctioned more than once: against a first-year intake of 120 the university admitted 116 in 2018-19 and then 132 in each of the two following years, on the NIRF filing.
The overshoot has an ordinary explanation, and the arithmetic is exact. Economically weaker section places are set at 10% of the total seats in each course and are added to the approved intake rather than carved out of it, in the reservation notes on the seat matrix. One tenth of a sanctioned 120 is 12, which is the whole distance between that figure and the 132 the university actually admitted in each of those two years, on its ranking submission.
Lateral entry is the quiet door into the second year, and it is quieter than it looks. The ranking submission records 21, then 22, then 20 students admitted by that route across three years, in the NIRF 2025 filing. Only a D.Pharm holder may use it, and 85% of those places are reserved for candidates who took their D.Pharm at DPSRU itself, leaving 15% for D.Pharm holders from any other institution approved by the Pharmacy Council, under the lateral entry rules. The university's own diploma is, in practice, the main route into its second year.
The rest of the matrix is cut by category before merit is applied, and the shares are published. 22.5% of seats in each course are reserved for Scheduled Caste and Scheduled Tribe candidates, split 15% and 7.5%; 27% within the Delhi category go to Other Backward Class candidates on the Delhi list with a valid non-creamy-layer certificate; a defence column runs down every course; and the economically weaker section block sits on top as supernumerary places, in the reservation pages. Those proportions are reissued every session, so read them against the year you are applying in rather than a copy saved from an earlier cycle.
Will You Get Into Delhi Pharmaceutical Sciences And Research University?
Not available yet
Admissions Deadline & Due Dates
Application deadlines
| Programme | Date | Year |
|---|---|---|
| various UG & PG programmesThe last date for submission of online application forms | 10 Jul 2026 (closed) | 2026-27 |
| Ph.D. Admissions 2026-27Apply online by | 10 Jul 2026 (closed) | 2026-27 |
Data source: DPSRU’s official website, as on 14 Nov 2026
Admissions Requirements
Not available yet
Get recruited by colleges
Explore Admissions at Similar Colleges
- Central University Of Punjab, Bathhinda
- Central University
- BATHINDA, PUNJAB
- NIRF Pharmacy #20
- National Institute Of Pharmaceutical Education And Research, Raebareli
- Central Government
- LUCKNOW, UTTAR PRADESH
- NIRF Pharmacy #17
- National Institute Of Pharmaceutical Education And Research (niper) - Ahmedabad
- Central Government
- GANDHINAGAR, GUJARAT
- NIRF Pharmacy #21
- Chitkara University, Patiala
- State Private University
- PATIALA, PUNJAB
- NIRF Pharmacy #16
- Banasthali Vidyapith
- Deemed University-Private
- TONK, RAJASTHAN
- NIRF Pharmacy #22
- Lovely Professional University
- State Private University
- KAPURTHALA, PUNJAB
- NIRF Pharmacy #13
- Isf College Of Pharmacy, Moga
- Private Un-Aided
- MOGA, PUNJAB
- NIRF Pharmacy #25
- National Institute Of Pharmaceutical Education And Research Guwahati
- Institute of National Importance
- KAMRUP, ASSAM
- NIRF Pharmacy #12
How hard is it to get into Delhi Pharmaceutical Sciences And Research University?
Not available yet
